Profile
NTRB VRTX REGN VRNA ARGX SGEN
Company Name Nutriband Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $50.04M $122.53B $81.42B $72.68B $51.58B $43.15B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 3.26K
CEO Gareth Sheridan Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren David R. Epstein
Ratings
NTRB VRTX REGN VRNA ARGX SGEN
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
NTRB VRTX REGN VRNA ARGX SGEN
Last Close $5.375 $434.02 $704.31 $106.91 $929.61 $228.74
High 52 $10.72 $513.76 $788 $106.91 $929.61 $228.74
Low 52 $3.85 $366.54 $482.92 $37.86 $532.27 $228.74
Price vs. 52 Week High -49.86 % -15.52 % -10.62 % 0 % 0 % 0 %
Price vs. 52 Week Low 39.61 % 18.41 % 45.84 % 182.38 % 74.65 % 0 %
Total Return
NTRB VRTX REGN VRNA ARGX SGEN
1 Month Return -28.14 % 4.13 % 21.84 % 0 % 10.19 % 0 %
3 Month Return -16.92 % 11.32 % 22.74 % 1.06 % 40.57 % 0 %
6 Month Return -4.36 % -1.06 % 18.51 % 49.92 % 64.35 % 0 %
9 Month Return -20.96 % -6.08 % 3.57 % 66.4 % 45.48 % 0 %
YTD Return 14.12 % 7.78 % -1.13 % 130.21 % 51.16 % 0 %
1 Year Return 9.47 % -3.12 % -5.41 % 180.68 % 61.8 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NTRB VRTX REGN VRNA ARGX SGEN
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1059.74 % 9.76 % 3.92 % -147.93 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
NTRB VRTX REGN VRNA ARGX SGEN
Asset Growth -0.63 % 7.41 % 53.91 % -1.21 %
Gross Profit Growth -18.88 % 1.16 % - 22.93 %
Revenue Growth 2.62 % 0.99 % - 24.65 %
Revenue 3 Year 12.54 % 20.64 % -15.89 % 91.56 %
Revenue 5 Year 244.45 % 73.64 % - 215.48 %
Revenue 10 Year - 285.02 % - 494.04 %
EBIT Growth -93.38 % 9.09 % -131.37 % -3.48 %
Net Income Growth -91.11 % 2.09 % -224.78 % 9.51 %
Net Income 3 Yeari Growth Per Share 6.91 % 6.32 % -148.34 % -763.59 %
Net Income 5 Yeari Growth Per Share -123.75 % 31.91 % 25.82 % -276.93 %
Net Income 10 Yeari Growth Per Share -1496465.12 % 680.22 % -35.51 % -624.16 %
Operating Income Growth -37.32 % -7.46 % -133.02 % 10.13 %
Operating Cash Flow Growth (CFG) -31.17 % - -143.33 % 9.07 %
Operating 3 Year CFG -23.18 % -100 % -170.73 % -147.99 %
Operating 5 Year CFG -208.61 % -100 % 54.81 % -195.86 %
Operating 10 Year CFG - -100 % 40.15 % -2622.09 %
EPS Growth -43.48 % 5.31 % -214.81 % 10.81 %
EPS Diluted Growth -43.48 % 8.19 % -208.93 % 10.81 %
Book Value Per Share -25.12 % 32.88 % -22.82 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -59.46 % 41.21 % 1.82 % 33.72 %
Share Holder 5 Year Equity Growth Per Share 2086.26 % 191.63 % -24.45 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 32107.37 % 842.11 % -71.86 % 691.19 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share -100 % - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -22.77 % 0.06 % 139.05 % -23.28 %
Free Cash Flow Growth -31.84 % - -144.48 % 3.67 %
Updated On 31 Jan 2025 31 Dec 2025 31 Dec 2024 31 Dec 2022
Profitability
NTRB VRTX REGN VRNA ARGX SGEN
Gross Profit Margin TTM 32.63 % 86.28 % 86.27 % 95.15 % 65.82 % 79.1 %
Return on Assets TTM -151.77 % 14.78 % 11.11 % -11.01 % 15.06 % -16.61 %
Return on Equity TTM -185.35 % 21.81 % 14.83 % -30.05 % 18.96 % -20.8 %
Return on Capital Employed TTM -121.11 % 19.59 % 10.3 % -8.31 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % 101.33 %
EBT Per Ebit TTM 137.98 % 111.4 % 146.19 % 130.36 % 147.38 % 98.26 %
EBIT Per Revenue TTM -406.46 % 34.06 % 24.95 % -25.86 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -2606.96 % 202.64 % 184 % -29.66 % 932.29 % -1043.73 %
Receivables Turnover TTM 15.44 6.02 2.5 1.93 1.91 3.91
Payables Turnover TTM 2.54 0.4 2.1 2.37 0.9 1.97
Inventory Turnover TTM 11.29 0.99 0.62 0.94 2.26 0.96
Fixed Asset Turnover TTM 340.57 % 388.59 % 280.11 % 6536.22 % 5009.77 % 665.41 %
Asset Turnover TTM 27.06 % 47.15 % 35.36 % 29.27 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.47 14.55 48.39 -0.85 5.67 -2.46
Free Cash Flow Per Share TTM -0.47 13.06 39.66 -0.85 5.58 -2.88
Cash Per Share TTM 44.06 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -247.64 % 31.71 % 34.71 % -43.23 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.91 % 89.76 % 81.96 % 100.75 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -2606.96 % 202.64 % 184 % -29.66 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -8.88 36.72 19.95 -995.27 129.37 -81.26
Price To Operating Cash Flows Ratio TTM -8.78 32.86 16.2 -126.33 146.05 -93.1
Price Cash Flow Ratio TTM -8.78 32.86 16.2 -126.33 146.05 -93.1
Income Statement (TTM)
NTRB VRTX REGN VRNA ARGX SGEN
Revenue $0B $12.07B $14.34B $0.03B $2.19B $1.96B
Gross Profit $0B $10.27B $12.24B $0.03B $1.96B $1.55B
Gross Profit Ratio 32.68% 85.03% 85.35% 93.89% 89.62% 79.1%
EBITDA $-0.01B $4.97B $5.82B $-0.12B $0.11B $-0.62B
Net Income $-0.01B $3.95B $4.5B $-0.14B $0.83B $-0.61B
EPS Diluted -0.99 15.32 41.48 -1.73 12.78 -3.3
Balance Sheet (MRQ)
NTRB VRTX REGN VRNA ARGX SGEN
Long Term Debt $0B $3.8B $2.71B $0.12B $0.03B $0.04B
Total Liabilities $0B $7.48B $9.3B $0.27B $0.7B $0.87B
Total Equity $0.01B $18.67B $31.26B $0.2B $5.5B $2.8B
Total Investments $0B $7.33B $15.75B $0.02B $1.93B $1.42B
Total Debt $0B $3.88B $2.71B $0.12B $0.04B $0.04B
Total Assets $0.01B $26.14B $40.56B $0.47B $6.2B $3.67B
Cash Flow Statement (TTM)
NTRB VRTX REGN VRNA ARGX SGEN
Net Income $-0.01B $3.95B $4.5B $-0.17B $0.83B $-0.61B
Inventory $-0B $-0.52B $-0.28B $-0.01B $-0.1B $-0.23B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0B $3.63B $4.98B $-0.12B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.44B $-0.9B $-0B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.51
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.99
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
ETFs With Exposure to NTRB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 336.65
VXF Vanguard Extended Market Index Fund 0.00029 216.28
IWC iShares Micro-Cap ETF 0 166.03
VUN.TO Vanguard U.S. Total Market Index ETF 0.00003 124.53
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00003 116.8
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.16
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.46
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.77
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.11
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.4
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 27.01
VTSAX Vanguard Total Stock Market Index Fund 0.00003 163.89
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00029 164.01
VITSX Vanguard Total Stock Market Index Fund 0.00003 163.92
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00029 164.02
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 475.91
VEMPX Vanguard Extended Market Index InstlPlus 0.00029 404.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 307.49
Unlock